Recombinant human erythropoietin pretreatment alleviates renal glomerular injury induced by cardiopulmonary bypass by reducing transient receptor potential channel 6-nuclear factor of activated T-cells pathway activation.
J Thorac Cardiovasc Surg
; 146(3): 681-7, 2013 Sep.
Article
em En
| MEDLINE
| ID: mdl-23535151
Palavras-chave
41.1; 41.3; ARI; CPB; EMSA; IP; NFAT; NFATc1; PBS; RhEPO; TRPC6; acute renal injury; canonical transient receptor potential channel 6; cardiopulmonary bypass; electrophoretic mobility shift assay; intraperitoneally; nuclear factor of activated T cell; nuclear factor of activated T-cells, cytoplasmic, calcineurin-dependent 1; phosphate-buffered saline; recombinant human erythropoietin
Texto completo:
1
Coleções:
01-internacional
Base de dados:
MEDLINE
Assunto principal:
Fatores de Transcrição
/
Ponte Cardiopulmonar
/
Eritropoetina
/
Substâncias Protetoras
/
Canais de Cátion TRPC
/
Fatores de Transcrição NFATC
/
Injúria Renal Aguda
/
Glomérulos Renais
Tipo de estudo:
Etiology_studies
/
Prognostic_studies
Limite:
Animals
/
Humans
/
Male
Idioma:
En
Revista:
J Thorac Cardiovasc Surg
Ano de publicação:
2013
Tipo de documento:
Article
País de afiliação:
China